The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
NEJM 332:993-997, 10251995., Khamashta,M.A.,et al, 1995
Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation
JAMA 274:1839-1845, Gage,B.F.,et al, 1995
The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995
Oral Sumatriptan in Prevent Headache Recurr after Trmt of Migraine with Subcut Sumatriptan
Neurol 45:1505-1509, Rappoport,A.M.,et al, 1995
Oral Sumatriptan for the Acute Treatment of Migraine:Eval of Three Dosage Strengths
Neurol 45:S5-S9, Cutler,N.,et al, 1995
Oral Sumatriptan is Effective & Well Tolerated for the Acute Trmt of Migraine:A Multictr Study
Neurol 45:S10-S14, S31995., Sargent,J.,et al, 1995
Oral Sumatriptan for the Long-Term Treatment of Migraine:Clinical Findings
Neurol 45:S15-S20, Rederich,G.,et al, 1995
Cardiac Arrest Following the Use of Sumatriptan
Neurol 45:1211-1213, Kelly,K.M., 1995
Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995
Oral Sumatriptan-Associated Transmural Myocardial Infarction
Neurol 45:2274-2276, O'Connor,P.&Gladstone,P., 1995
Acetylcholine Receptor Antibodies in Patients with Graves'Ophthalmopathy
J Neuro-Ophthalmol 15:166-170, Jacobson,D.M., 1995
Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995
The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995
Analgesic Headache
BMJ 310:479-480, Olesen,J., 1995
Myasthenia Gravis During Interferon Alfa Therapy
Neurol 45:382-383, Batocchi,A.P.,et al, 1995
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
Optimal Oral Anticoag Therapy in Pts with Nonrheumatic Atrial Fib & Recent Cerebral Ischemia
European Atrial Fib Study Group, NEJM 333:5-10, 54995., , 1995
Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995
Oral Anticoagulants and Intracranial Hemorrhage, Facts and Hypotheses
Srroke 26:1471-1477, Hart,R.G.,et al, 1995
The Warfarin-Aspirin Symptomatic Intracranial Disease Study
Neurol 45:1488-1493, Chimowitz,M.I.,et al, 1995
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
NEJM 333:11-17, 541995., Cannegieter,S.C.,et al, 1995
The Effect of Nimodipine on Essential Tremor
Neurol 45:1523-1525, Biary,N.,et al, 1995
Postpartum Cerebral Angiopathy Possibly Due to Bromocriptine Therapy
Stroke 26:128-130, Janssens,E.,et al, 1995
Sneddon's Syndrome is a Thrombotic Vasculopathy:Neuropathologic and Neuroradiologic Evidence
Neurol 45:557-560, Geschwind,D.H.,et al, 1995
Stroke Prevention Therapies and Management of Patient Subgroups
Neurol 45:S19-S24, Raps,E.C.&Galetta,S.L., 1995
Drugs and Surgery in the Prevention of Ischemic Stroke
NEJM 332:238-248, Barnett,H.J.M.,et al, 1995
Myasthenic Symptoms in Patients with Mitochondrial Myopathies
Muscle & Nerve 18:1338-1340995., Forestier,N.L.,et al, 1995
Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995
A Multicenter Double-Blind Placebo-Controlled Trial of Pergolide as an Adjunct to Sinemet in Parkinson's Disease
Movement Disorders, 9:40-471994., Olanow,C.W.,et al, 1994
Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994
Phenytoin and Ranitidine Interaction
Ann Int Med 120:892-893, Tse,C.S.T.&Iagmin,P., 1994
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 25:2315-2328, Mayberg,M.R.,et al, 1994
Treatment with D-penicillamine Improves Dopamine D2-Receptor Binding and T2-Signal Intensity in de novo Wilson's Disease
Neurol 44:1079-1082, Schwarz,J.,et al, 1994
Migraine:A Pharmacologic Review with Newer Options and Delivery Modalities
Neurol 44:S13-S17, Baumel,B., 1994
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
Congenital Myasthenic Syndromes
In:Neurologic Clinics, 12:401-4371994., Engel,A.G., 1994
Race, Sex, and Puberty Influence Onset, Severity, and Outcome in Juvenile Myasthenia Gravis
Neurol 44:1208-1214, Andrews,P.I.,et al, 1994
Subcutaneous Sumatriptan During the Migraine Aura
Neurol 44:1587-1592, Bates,D.,et al, 1994
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Patent Foramen Ovale and Brain Infarct:Echocardiographic Predictors, Recurrence, and Prevention
Stroke 25:782-786, Hanna,J.P.,et al, 1994
Reverse Shapiro's Syndrome:Hirayama
K. , et al, Arch Neurol 51:494-49694., , 1994
A Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke
Stroke 25:1348-1353, Kaste,M.,et al, 1994
A Follow-up Survey of Clinical Practices for the Use of Heparin, Warafarin, & Aspirin
Neurol 44:618-621, Alberts,M.J.,et al, 1994
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Ann Int Med 120:897-902, Hylek,E.M.&Singer,D.E., 1994
Medical Treatment for Stroke Prevention
Ann Int Med 121:41-55, Matchar,D.B.,et al, 1994
Warfarin Versus Aspirin for Prevention of Thromboembolism in Atrial Fibrillation:SPAF II Study
SPAF-II Investigators, Lancet 343:687-691, 683994., , 1994
Is There a Problem with Long Term Use of Sumatriptan in Acute Migraine?
BMJ 308:113, Osborne,M.J.,et al, 1994
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Fluctuating Parkinson's Disease:Treatment with the Long-Acting Dopamine Agonist Cabergoline
Arch Neurol 51:1236-1241, Ahlskog,J.E.,et al, 1994
Clinical Exper from Sweden on Use of Subcutaneously Admin Sumatriptan in Migraine & Cluster Headache
Arch Neurol 51:1256-1261, Dahlof,C.,et al, 1994